Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives

Carcinosarcomas (CS) in gynecology are very infrequent and represent only 2–5% of uterine cancers. Despite surgical cytoreduction and subsequent chemotherapy being the primary treatment for uterine CS, the overall five-year survival rate is 30 ± 9% and recurrence is extremely common (50–80%). Due to...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Mol Sci
Glavni autori: Vitale, Salvatore Giovanni, Laganà, Antonio Simone, Capriglione, Stella, Angioli, Roberto, La Rosa, Valentina Lucia, Lopez, Salvatore, Valenti, Gaetano, Sapia, Fabrizio, Sarpietro, Giuseppe, Butticè, Salvatore, Tuscano, Carmelo, Fanale, Daniele, Tropea, Alessandro, Rossetti, Diego
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2017
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455008/
https://ncbi.nlm.nih.gov/pubmed/28531111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18051100
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items